World Haemophilia Day: Equitable access for all, recognising all bleeding disorders [Article]

The look on her face was priceless; shock, disbelief and grief mixed with relief as her eyes glistened with tears.

“So, I’m not a witch after all, I did not kill my sons” …. And she kept repeating those words. Why didn’t anyone tell her this earlier, but alas better late than never. A cloud of darkness has been lifted off her head and finally an answer to the musings of her heart.

She is a single mother of 3 healthy girls but unfortunately, the son her husband craved so much had eluded her. She had just been told by the doctor that her deceased sons, four sons who were very healthy at birth, had died from post-circumcision bleeding caused by haemophilia; a disease that means “loves to bleed”.

Hemophilia is a bleeding disorder where an individual’s blood does not clot properly due to lack of sufficient blood-clotting proteins (clotting factor) which help to stop bleeding. Affected individuals can bleed spontaneously or bleed excessively following an injury or surgery. Its origins predate the Talmud era, where the third son of a woman who had lost two previous sons from post-circumcision bleeding was spared from the procedure.

In modern times, Hemophilia has featured prominently in European royalty and thus is sometimes known as ‘the royal disease’. Queen Victoria passed the mutation for haemophilia B to her son Leopold and, through two of her daughters, Alice and Beatrice, to various royals across the continent, including the royal families of Spain, Germany, and Russia.

The Science of the Disorder

Hemophilia is a genetic disorder meaning the condition is mostly inherited. There are two main types of hemophilia; hemophilia A and hemophilia B and affected persons have low levels of clotting factors VIII and XI respectively. The disease is caused by a mutation in a gene which sits on the X chromosome.

Males have one X and one Y chromosome (XY) and females have two X chromosomes (XX). Hence males are affected when they inherit an affected X chromosome from their mothers. The disease consequently affects more males than females, as males have only one X chromosome.

A female carrying the defect on one of her X chromosomes may not be affected by it. A mother who is a carrier has a 50% chance of passing the faulty X chromosome to her daughter, while an affected father will always pass on the affected gene to his daughters. A son cannot inherit the defective gene from his father. Although haemophilia commonly runs in families, for 1 in every 3 patients seen, the individual may be the first one in the family to be affected with a change in the gene that codes for the clotting factor.

Incidence of the disorder

Hemophilia affects all races and ethnic groups with an occurrence of 1 in every 10,000 births. Worldwide, about 400,000 people are living with the disease and in Ghana we have over 500 patients identified and diagnosed in our registry. However, based on the estimated prevalence based on our population numbers, there could be over 3000 people living with hemophilia in Ghana meaning that we have yet to identify over two thousand potential patients to be diagnosed and offered comprehensive care.

Patients with this disease commonly present with bleeds in joints and muscle causing swellings, pain and tightness. They have easy bruising, nose bleeds, gum bleeds and bleeds are difficult to control after losing a tooth. They may even present with blood in their stools and urine, post vaccination bleeds as well as life threatening bleeding in the head, chest or abdomen.

The earliest symptom that could point to this diagnosis could be cord bleed, scalp bleeds and most importantly post circumcision bleed. Post circumcision bleed has been the bane of most marriages as couples lose their sons from excessive bleeding after the procedure.

Gene therapy, which is supposed to be the panacea to the treatment of this disorder, has reached advanced stages and yet to be rolled out worldwide.

Medication

The best way to treat hemophilia is to replace the missing clotting factor so that the blood can clot properly. Currently in Ghana, two comprehensive Hemophilia treatment centers have been established in Komfo Anokye teaching hospital and Korle-bu teaching hospital where patients are offered comprehensive care to improve their overall quality of life. These centers were established with the support of the Ghana hemophilia society (GHS), a non-profit organization founded by a parent Mr. Martin Boakye in 2009. GHS educates, trains health workers and advocates for people living with hemophilia and the society has gained its recognition and membership from the

World Federation of Hemophilia, Canada. Through the support of WFH, GHS also benefits from the humanitarian aid program where the society receives these expensive clotting factors for Ghanaian patients living with hemophilia at no cost to the patients. On the average, over $3 million dollars of donations are received every year from the world body to the society on behalf of the patients.

Essential Support from Government

Majority of the patients however cannot afford the laboratory investigations required in the diagnosis and management of this disease. Like most chronic diseases, mothers of children with hemophilia are left to shoulder the burden of all the required laboratory investigations by themselves and the peculiarities in the mode of inheritance even worsens this situation as fathers blame the mothers for the condition with some shirking their responsibilities towards their affected children.

In recent times, the society has stepped up efforts to get the government to give the patients of hemophilia equal attention in medical care. I am glad to note that this advocacy has reached advanced stage to get the hemophilia care unto the National health insurance scheme. When it is done these patients will benefit from:

a. Laboratory diagnosis: screening and coagulation (assays) analysis

b. Procurement of essential drugs to augment the existing inflow of donations
These have been the bane of many potential patients who, for lack of funds, refuse even to get screened and therefore do not get factor treatment.

The World Hemophilia Day

World Hemophilia Day is an international observance day held on the 17th of April every year by the WORLD Federation of Hemophilia (WFH) and its affiliate National Member Organizations (NMOs). This year, the theme is ‘Equitable access for all”. It is a call to help increase awareness of the inherited bleeding disorders including hemophilia and to make adequate care accessible to every patient who needs it in the various communities. With WFH shouldering a bigger portion of the responsibility involved in management of hemophilia, the government of Ghana could also consider adding hemophilia to the diseases under NHIS to not only lighten the burdens of affected families but also to help close the gap in the care of these patients.

---

Explore the world of impactful news with CitiNewsroom on WhatsApp!

Click on the link to join the Citi Newsroom channel for curated, meaningful stories tailored just for YOU: https://whatsapp.com/channel/0029VaCYzPRAYlUPudDDe53x

No spams, just the stories that truly matter! #StayInformed #CitiNewsroom #CNRDigital

The post World Haemophilia Day: Equitable access for all, recognising all bleeding disorders [Article] appeared first on Citinewsroom - Comprehensive News in Ghana.

Read Full Story